By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix will use TriLink Biotechnologies' oligonucleotides in several of its kits under an agreement announced today by the firms.

The partners did not disclose terms of the agreement, but said it is a multi-year distribution and supply pact. They also did not specify which Affy kits would contain the oligos.

San Diego-based TriLink makes custom oligos, modified nucleoside triphosphates and CleanAmp PCR products for the diagnostics and OEM markets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.